Moderna CEO says people may need fourth Covid shot as efficacy of boosters likely to decline over timeCNBC • 01/06/22
Moderna Announces First Participant Dosed in Phase 1 Study of its mRNA Epstein-Barr Virus (EBV) VaccineAccesswire • 01/05/22
Moderna to Present at the Goldman Sachs 14th Annual Healthcare CEOs Unscripted ConferenceAccesswire • 01/04/22
Moderna shipped 800 million COVID vaccines last year, more than tripled its cash position but stock falls againMarket Watch • 01/04/22
Moderna to Provide Business and Pipeline Updates at the 2022 J.P. Morgan Healthcare ConferenceAccesswire • 01/03/22
Moderna's on the Rise, but This Small Biotech Is the Nasdaq's Big Winner on New Year's EveThe Motley Fool • 12/31/21